Feburic tablets 20mg from Teijin Pharma contain Febuxostat, a non-purine selective inhibitor of xanthine oxidase used to manage hyperuricemia in patients with gout. This medication has the YJ code 3949003F2020 and a standard of 20mg 1 tablet.
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
This website contains information intended for healthcare professionals, including physicians, pharmacists, and other medical staff.
Please confirm that you are a healthcare professional before continuing.
* Your selection will be saved on this device and will not be asked again for a certain period.